How Plasma Collection Growth and Device Innovation Are Powering the Global Hemapheresis Market to USD 8.4 Billion by 2035

The global hemapheresis market was valued at $3.8 billion in 2024 and is projected to reach $8.4 billion by 2035, growing at a CAGR of 7.6% during the forecast period (2025-2035). The global hemapheresis market is witnessing strong growth due to the increasing prevalence of chronic, autoimmune, and haematological disorders that require plasma- and blood-component–based therapies. Growing clinical use of therapeutic apheresis in conditions such as autoimmune diseases, neurological disorders, and rare blood disorders is boosting demand across hospitals and speciality clinics.

Browse the full report description of “Hemapheresis Market Size, Share & Trends Analysis Report by Technology (Centrifugation, Membrane Separation, Selective Adsorption) by Product (Hemapheresis Devices, and Hemapheresis Disposables) by Procedure (Photopheresis, Plasmapheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, and Others), and By Application (Hematology, Neurology, Renal Disease, and Others) Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/hemapheresis-market

The expansion of plasma collection centers, supported by favourable regulatory frameworks and reimbursement policies in several regions, is strengthening plasma supply chains. Continuous technological advancements in hemapheresis devices—such as improved safety features, higher collection efficiency, and enhanced patient comfort—are further accelerating market adoption.

Global Developments Highlighting Market Momentum

• 2024: The growing incidence of autoimmune and neurological disorders increased the clinical adoption of therapeutic apheresis across hospitals and specialty treatment centers worldwide.
• 2024-2025: Plasma collection organizations expanded collection facilities in North America and Europe, supported by regulatory approvals and rising demand for plasma-derived medicines.
• 2025: Leading manufacturers introduced next-generation hemapheresis devices with enhanced automation, real-time monitoring, and improved donor comfort to optimize operational efficiency.

Capacity Expansion and Technology Upgrades

Industry players are investing in advanced hemapheresis systems with automation, digital monitoring, and disposable kits to improve collection efficiency and donor safety. Companies are also expanding plasma collection networks and collaborating with healthcare providers to ensure regulatory compliance and meet the rising global demand for plasma-derived therapies.

Innovative Solutions, Strategic Collaborations, and Broader Clinical Adoption

• In 2025, Terumo BCT, Inc. introduced its latest automated hemapheresis system featuring enhanced cell separation precision, streamlined workflows, and integrated safety controls to support large-volume plasma collection and therapeutic apheresis applications across clinical settings.
• In 2024, Fresenius Kabi AG completed the acquisition of a specialized blood component processing technology provider, strengthening its portfolio of hemapheresis products and expanding its capabilities in therapeutic plasma exchange and cell therapy support services.
• In 2025, Haemonetics Corporation announced a strategic collaboration with a leading global blood services network to advance standardization of hemapheresis procedures, expand training programs for clinicians, and improve operational efficiencies in blood collection centers worldwide.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• Technology
• Product
• Procedure
• Application

• Competitive Landscape – Asahi Kasei Medical, Braun Melsungen AG, Fresenius Medical Care, Haemonetics Corp. and Terumo BCT.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Hemapheresis Market Report Segment

By Technology

• Centrifugation
• Membrane Separation
• Selective Adsorption

By Product

• Hemapheresis Devices
• Hemapheresis Disp

By Procedure

• Photopheresis
• Plasmapheresis
• Plateletpheresis
• Leukapheresis
• Erythrocytapheresis
• Others

By Application

• Hematology
• Neurology
• Renal Disease
• Others (Autoimmune Disorder)

Global Hemapheresis Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/hemapheresis-market